...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: BIO Investor Forum, Oct 22-23

Just had a look at the presentation. Seems like a rehash of old stuff. Looks like things are proceeding on the science side (sort of plodding along) but there is nothing at all from an investor or business side.

I sure hope I missed something. Seems very disappointing...a real let down. Sure hope others will review and flush some positive progress.

Toinv

Share
New Message
Please login to post a reply